{"disease":{"id":"internuclear-ophthalmoplegia","name":"internuclear ophthalmoplegia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05338450","title":"Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT06629155","title":"Studying Eye Movement Deficits and Cognitive Impairment in Patients with Multiple Sclerosis Using Infrared Eye Tracking and Cognitive Tests","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Universitair Ziekenhuis Brussel","has_results":false},{"nct_id":"NCT06417216","title":"Head-Cancelled Virtual Reality for Ocular Cranial Nerve Palsies","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Kevin Houston","has_results":false},{"nct_id":"NCT02391961","title":"Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"VA Office of Research and Development","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}